Loading...
SeniorFull-timeRust
Salary Range
$38,454 - $52,026 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
We are looking for a Key Account Manager based in Finland to drive strategic engagement and long-term partnerships across priority hospital and regional accounts. This role will play a pivotal role in shaping Sobi’s presence in the nephrology market and maintain and expand the Hematology market.
Key Responsibilities
- →Lead the development and execution of strategic account plans for key nephrology centers and regional stakeholders
- →Build trusted, long-term partnerships with KOLs, clinicians, payers, and decision-makers
- →Drive cross-functional collaboration across medical, market access, and marketing to deliver aligned customer solutions
- →Capture, analyze, and share actionable insights to inform brand strategy, market access, and lifecycle management
- →Support launch readiness, omnichannel initiatives, and local adaptation of marketing materials
- →Navigate local market access and HTE frameworks, translating insights into value-based stakeholder discussions
- →Analyze market trends, competitor activity, and treatment pathways to identify growth opportunities
- →Ensure high standards of compliance, ethics, and CRM reporting
- →Represent Sobi at national congresses and lead impactful stakeholder engagements
Requirements
- ✓Advanced account management skills with marketing-driven brand support activities
- ✓Experience in nephrology and hematology markets
- ✓Strong ability to drive cross-functional execution and implementation of account plans
- ✓Excellent communication and stakeholder engagement skills
- ✓Knowledge of market access and HTE frameworks
- ✓Ability to analyze market trends and competitor activity
- ✓Compliance and ethics expertise
- ✓CRM reporting experience
Free to sign up. Takes 30 seconds.
About Sobi
Sobi is a global specialty biopharmaceutical company focused on developing and delivering innovative therapies for patients with rare and severe diseases. Headquartered in Sweden, the company has established a strong presence in the life sciences industry, leveraging its expertise to address unmet medical needs. Founded with a commitment to improving patient outcomes, Sobi has grown into a leader in the rare disease sector, operating across multiple countries to bring life-changing treatments to those who need them most. Sobi’s main products and services include the development, manufacturing, and commercialization of specialty medicines, with a particular emphasis on hematology, immunology, and rare diseases. The company’s portfolio features therapies that target conditions such as hemophilia, immunoglobulin deficiencies, and inherited metabolic disorders. Key features of Sobi’s offerings include advanced treatment options, personalized care approaches, and robust patient support programs. The company primarily serves patients, healthcare providers, and institutions, focusing on communities affected by rare and complex conditions. Notable achievements include the successful launch of several breakthrough therapies and strategic acquisitions that have expanded Sobi’s capabilities and market reach. The company is recognized for its innovative research and patient-centric approach, positioning it as a trusted partner in the rare disease community. Sobi’s unique value proposition lies in its dedication to rare diseases, combining scientific excellence with a deep understanding of patient and caregiver needs to deliver meaningful treatments.
